Cardinal Health (CAH) Raising Eyebrows Among Investors

Cardinal Health, Inc. (NYSE:CAH) is on our radar right now but there could still be some opportunities on the horizon. Now trading with a market value of 19.02B, the company has a mix of catalysts and obstacles that spring from the nature of its operations. As the day-to-day narrative ebbs and flows for this company, it is more important than ever to step back and get a bird’s eye view of the fundamental reality under the surface of this story.

Cardinal Health, Inc. (NYSE:CAH) Fundamentals That Matter

It’s generally a good idea to start with the most fundamental piece of the picture: the balance sheet. The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For CAH, the company currently has 1.18 billion of cash on the books, which is offset by 935 million in current liabilities. The trend over time is important to note. In this case, the company’s debt has been growing. The company also has 41.94 billion in total assets, balanced by 35.23 billion in total liabilities, which should give you a sense of the viability of the company under any number of imagined business contexts.

Cardinal Health, Inc. (CAH) saw 1.11 billion in free cash flow last quarter, representing a quarterly net change in cash of -5.7 billion. Perhaps most importantly where cash movements are concerned, the company saw about 1.18 billion in net operating cash flow.

Cardinal Health, Inc. (NYSE:CAH) Revenue Growth Potential

As far as key trends that demonstrate something of the future investment potential of this stock, we need to take a closer look at the top line, first and foremost. Last quarter, the company saw 32.64 billion in total revenues. That represents a quarterly year/year change in revenues of 0.02 in sequential terms, the CAH saw sales decline by -0.01.

But what about the bottom line? After all, that’s what really matters in the end. Cardinal Health, Inc. (CAH) is intriguing when broken down to its core data. The cost of selling goods last quarter was 31.1 billion, yielding a gross basic income of 1.54 billion. For shareholders, given the total diluted outstanding shares of 318 million, this means overall earnings per share of 0.36. Note, this compares with a consensus analyst forecast of 1.14 in earnings per share for its next fiscal quarterly report.

Is Cardinal Health, Inc. (NYSE:CAH) Valuation Attractive

Looking ahead at valuations, according to the consensus, the next fiscal year is forecast to bring about 5.51 in total earnings per share. If we consider a median price to earnings ratio on the stock, that corresponds with a stock price of 11.06. However, one should always remember: the trends are more important than the forecasts. This continues to be an interesting story, and we look forward to updating it again soon on Cardinal Health, Inc..

Previous ArticleNext Article

Related Post

Comparing Micron Technology, Inc. (MU) and ADT Inc... Micron Technology, Inc. (NASDAQ:MU) shares are up more than 31.35% this year and recently increased 3.35% or $1.75 to settle at $54.01. ADT Inc. (NYSE...
Which of 2 stocks would appeal to long-term invest... The shares of Sarepta Therapeutics, Inc. have increased by more than 13.48% this year alone. The shares recently went up by 5.99% or $3.57 and now tra...
Critical Comparison: Altice USA, Inc. (ATUS) vs. A... Altice USA, Inc. (NYSE:ATUS) shares are down more than -0.69% this year and recently decreased -3.50% or -$0.69 to settle at $19.01. ARCA biopharma, I...
Sunrun Inc. (RUN) vs. BlackLine, Inc. (BL): Compar... Sunrun Inc. (NASDAQ:RUN) shares are up more than 128.64% this year and recently increased 6.72% or $0.85 to settle at $13.49. BlackLine, Inc. (NASDAQ:...
Comparing Valuation And Performance: Office Depot,...   The shares of Office Depot, Inc. have decreased by more than -30.51% this year alone. The shares recently went down by -3.53% or -$0.09 and ...